Mannequin-Based Simulation - Global Strategic Business Report

The global market for Mannequin-Based Simulation is estimated at US$2.2 Billion in 2023 and is projected to reach US$6.1 Billion by 2030, growing at a CAGR of 15.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the mannequin-based simulation market is driven by several factors. Firstly, the increasing complexity of medical procedures and the need for precision and competence have made simulation-based training essential. Secondly, advancements in mannequin technology, including improved realism and interactivity, have enhanced the training experience and outcomes. Thirdly, there is a growing emphasis on patient safety and the reduction of medical errors, which has led to the widespread adoption of simulation training in medical curricula. Lastly, the ongoing shortage of clinical training sites and the need for efficient, scalable training solutions have further propelled the demand for mannequin-based simulation. These factors collectively ensure the continued expansion and innovation within the mannequin-based simulation market.

Key Insights:

Market Growth: Understand the significant growth trajectory of the Patient Simulators segment, which is expected to reach US$4.1 Billion by 2030 with a CAGR of a 15.4%. The Other Product Types segment is also set to grow at 16.9% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, estimated at $892.3 Million in 2023, and China, forecasted to grow at an impressive 18.9% CAGR to reach $347.4 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Mannequin-Based Simulation Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Mannequin-Based Simulation Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Mannequin-Based Simulation Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Moog, Inc., Laerdal Medical AS, Ambu A/S, and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 55 Featured):

Moog, Inc.
Laerdal Medical AS
Ambu A/S
3B Scientific GmbH
Cardionics
DentalEZ, Inc.
Gaumard Scientific Co., Inc.
IngMar Medical
Kyoto Kagaku Co., Ltd.
Mentice AB
CAE Healthcare
Adam Rouilly Ltd.
Global Technologies
KOKEN CO., LTD.
LifeCast Body Simulation Ltd.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Economic Update
COVID-19 Impact on Mannequin-Based Simulation
Mannequin - A Prelude
Simulation Based Education
Nursing Education Embraces Simulation-based Learning in a Major Way
Mannequin-based Simulation: An Integral Part of Medical Simulation Market
Global Mannequin-based Simulation Market Set to Witness Significant Growth
Growth Drivers
Increasing Focus on Patient Safety
Limited Access to Live Patients Drives Market for Simulation
Simulation in Healthcare Enables Cost Reduction
Technology Revolution Drives Demand for Simulation
Affordability & Rising Implementation to Boost Demand
Developed Regions: Primary Revenue Contributors
Developing Regions Offer High Growth Potential for Mannequin-based Simulation
Patient Simulators Lead the Mannequin-based Simulation Market
Competition
Mannequin-Based Simulation - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Increase in Surgeries Augurs Well for Market Growth
Global Surgical Procedure Volume by Procedure Type
Rise in Number of Surgeries & Shortage of Surgeons Drive Use of Mannequin-based Simulation for Surgeon Education and Training
Surgical Backlog & Surgeon Shortages: A Harrowing Situation
Cancer Surgery Demand Surges Amid Surgeon Shortage
Mannequin-based Simulation to the Rescue
As the Number of Surgeries Performed Globally Increase, the Need for Well Trained Surgeons Becomes Acute, Strengthening the Business Case for Mannequin-based Simulation: Global Market for General Surgery (In US$ Billion) for Years 2018, 2020, 2022, 2024, 2026 and 2028
Virtual Simulation and High-Fidelity Mannequin Simulation for Recognizing Critical Events
High-fidelity Mannequins
Advanced Mannequins Imitate Human Reactions
Increasing Healthcare Expenditure to Foster Growth
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
Mannequin-based Simulation for Nursing Schools
Cardiology, a Promising Field for Medical Animation/Simulation
Simulation Benefits Interventional Cardiology
Mannequins Gain Traction in Military Medical Training
Minimally-invasive Procedures Necessitate Simulation-based Training
Robot-assisted Surgical Simulation Training Gaining Significance
Simulation Training Preferred for Cataract Surgery
Surgical Simulation Gets Notable Makeover with Influx of Innovative Approaches
Surgical Simulation: The History & Evolution
Existing Surgical Simulation Models
Continuing Advances Pave Way for Versatile & Realistic Surgical Simulators
Innovations Set to Take Surgical Simulation to Next Level
Select Innovations
Learning Theories Guiding Development of Simulation-based Education
Areas where Under Graduate Nursing Education Simulation is Most Used
Virtual Simulations for UG Nursing Programs

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Mannequin-Based Simulation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
Table 2: World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 3: World Historic Review for Mannequin-Based Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 4: World 16-Year Perspective for Mannequin-Based Simulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
Table 5: World Recent Past, Current & Future Analysis for Patient Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 6: World Historic Review for Patient Simulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 7: World 16-Year Perspective for Patient Simulators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 8: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 9: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 10: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 11: World Recent Past, Current & Future Analysis for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 12: World Historic Review for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 13: World 16-Year Perspective for Academics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES

Mannequin-Based Simulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Table 20: USA Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 21: USA Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 22: USA 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 23: USA Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 24: USA Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 25: USA 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

CANADA

Table 26: Canada Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 27: Canada Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 28: Canada 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 29: Canada Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 30: Canada Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 31: Canada 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

JAPAN

Table 32: Japan Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 33: Japan Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 34: Japan 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 35: Japan Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 36: Japan Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 37: Japan 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

CHINA

Table 38: China Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 39: China Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 40: China 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 41: China Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 42: China Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 43: China 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

EUROPE

Mannequin-Based Simulation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Table 44: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 45: Europe Historic Review for Mannequin-Based Simulation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 46: Europe 16-Year Perspective for Mannequin-Based Simulation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
Table 47: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 48: Europe Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 49: Europe 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 50: Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 51: Europe Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 52: Europe 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

FRANCE

Table 53: France Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 54: France Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 55: France 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 56: France Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 57: France Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 58: France 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

GERMANY

Table 59: Germany Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 60: Germany Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 61: Germany 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 62: Germany Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 63: Germany Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 64: Germany 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

ITALY

Table 65: Italy Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 66: Italy Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 67: Italy 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 68: Italy Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 69: Italy Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 70: Italy 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

UNITED KINGDOM

Table 71: UK Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 72: UK Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 73: UK 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 74: UK Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 75: UK Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 76: UK 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

REST OF EUROPE

Table 77: Rest of Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 78: Rest of Europe Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 79: Rest of Europe 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 80: Rest of Europe Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 81: Rest of Europe Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 82: Rest of Europe 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

ASIA-PACIFIC

Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 84: Asia-Pacific Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 85: Asia-Pacific 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 87: Asia-Pacific Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 88: Asia-Pacific 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

REST OF WORLD

Table 89: Rest of World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 90: Rest of World Historic Review for Mannequin-Based Simulation by Product Type - Patient Simulators and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 91: Rest of World 16-Year Perspective for Mannequin-Based Simulation by Product Type - Percentage Breakdown of Value Sales for Patient Simulators and Other Product Types for the Years 2014, 2024 & 2030
Table 92: Rest of World Recent Past, Current & Future Analysis for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 93: Rest of World Historic Review for Mannequin-Based Simulation by End-Use - Academics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 94: Rest of World 16-Year Perspective for Mannequin-Based Simulation by End-Use - Percentage Breakdown of Value Sales for Academics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

Companies Mentioned

Moog, Inc.
Laerdal Medical AS
Ambu A/S
3B Scientific GmbH
Cardionics
DentalEZ, Inc.
Gaumard Scientific Co., Inc.
IngMar Medical
Kyoto Kagaku Co., Ltd.
Mentice AB
CAE Healthcare
Adam Rouilly Ltd.
Global Technologies
KOKEN CO., LTD.
LifeCast Body Simulation Ltd.

Table Information

Report Attribute	Details
No. of Pages	268
Published	November 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 2.2 Billion
Forecasted Market Value ( USD ) by 2030	$ 6.1 Billion
Compound Annual Growth Rate	15.9%
Regions Covered	Global
No. of Companies Mentioned	15

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5471EUR$5,600USD£4,568GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10396EUR$10,640USD£8,679GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€16414EUR$16,800USD£13,703GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 55 Featured):

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Mannequin-Based Simulation Market by Type, End-Users - Global Forecast 2025-2030

Mannequin-based Simulation Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Healthcare/Medical Simulation - Global Strategic Business Report

Surgical Simulation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Commercial and Military Flight Simulation - Global Strategic Business Report